Skip to Content

Ultomiris

Licence status
Withdrawn: 22/09/2025
Active substances
RAVULIZUMAB
Dosage Form
Solution for injection
Licence number
EU/1/19/1371/004
Licence holder
Alexion Europe S.A.S.

Licence information

ATC code
L04AA43 ravulizumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
31/05/2023